Knud Erik Mogensen

Title: Knud Erik Mogensen: Innovator in Interferon Research

Introduction

Knud Erik Mogensen is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of interferon research. With a total of 5 patents, Mogensen's work has had a profound impact on medical diagnostics and therapeutic applications.

Latest Patents

Mogensen's latest patents include innovative developments such as water-soluble polypeptides that exhibit a high affinity for both alpha and beta interferons. These patents also encompass DNA sequences and expression cells, along with methods for their preparation. Additionally, he has worked on drugs and compositions that utilize these polypeptides as diagnostic agents or for the production of antibodies. Another significant patent involves a purified human alpha interferon receptor, which relates to the purification of this important receptor.

Career Highlights

Throughout his career, Mogensen has been associated with several prominent companies, including Leb-Tech and Medisup International. His work in these organizations has allowed him to advance his research and contribute to the development of new medical technologies.

Collaborations

Mogensen has collaborated with esteemed colleagues such as Ion Gresser and Georges Lutfalla. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.

Conclusion

Knud Erik Mogensen's contributions to biotechnology and interferon research are noteworthy. His innovative patents and collaborations have paved the way for advancements in medical diagnostics and therapeutics. His work continues to influence the field and inspire future research endeavors.